EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Regulation of the anorectic drug recognition site during glucoprivic feeding


Brain Research Bulletin 28(2): 201-208
Regulation of the anorectic drug recognition site during glucoprivic feeding
The acute effects of 2-deoxy-D-glucose (2-DG)-induced glucoprivic feeding on the anorectic drug recognition site and Na+K+-ATPase in the brain were examined in adult rats and in lean and genetically obese mice. The marked hyperglycemia and the induction of feeding caused by the administration of 2-DG to satiated rats and lean mice were associated with significant increases in Na+K+-ATPase activity, and in [3H]ouabain binding and [3H]mazindol binding to the anorectic drug recognition site in hypothalamic membranes. Basal and 2-DG-stimulated levels of blood glucose were significantly correlated to the levels of hypothalamic [3H]ouabain (r = + .91, p < 0.01) and [3H]mazindol (r = + .87, p < 0.01) binding. A significant correlation (r = .74, p < 0.05) was also observed [3H]mazindol binding and [3H]ouabain binding supporting the hypothesis that these hypothalamic binding sites are functionally coupled in their response to circulating glucose. Following the intracerebroventricular (ICV) administration of the diabetogenic drug alloxan, 2-DG did not stimulate feeding or increase [3H]mazindol and [3H]ouabain binding sites in the hypothalamic paraventricular area. Since 2-DG still caused hyperglycemia in alloxan-treated rats, alloxan-induced inactivation of glucoreceptor mechanisms led to an uncoupling of the anorectic drug recognition site from a hypothalamic glucostat. In genetically obese mice (ob/ob), 2-DG also could not induce feeding or increase hypothalamic [3H]ouabain or [3H]mazindol binding, despite a significant hyperglycemic response. In contrast, 2-DG did increase feeding and the binding of [3H]ouabain and [3H]mazindol to the hypothalamus of lean littermates. The dissociation of the anorectic drug recognition site from blood glucose responses to 2-DG suggests that the glucoprivic feeding response in obese mice is impaired. In conclusion, the [3H]mazindol recognition site and the neuronal Na+KP+-ATPase KP+-ATPase labelled by [3H]ouabain binding constitutes a glucoreceptive system which is response to changes in circulating glucose levels modulates feeding. Since the coupling of this anorectic drug recognition site to brain glucostats is defective in genetically obese mice, this system may have an important role in pathological hyperphagia and the development of obesity.

Accession: 002477282

PMID: 1317740

DOI: 10.1016/0361-9230(92)90180-6

Download PDF Full Text: Regulation of the anorectic drug recognition site during glucoprivic feeding



Related references

Site of action of anorectic drugs: glucoprivic- versus food deprivation-induced feeding. Pharmacology, Biochemistry, and Behavior 27(2): 291-297, 1987

Defective glucostatic regulation of anorectic drug recognition sites and sodium potassium atpase in genetically obese mice. Society for Neuroscience Abstracts 12(2): 795, 1986

Regulation of [3H]mazindol binding to subhypothalamic areas: involvement in glucoprivic feeding. Brain Research Bulletin 17(6): 873-877, 1986

Regulation of tritiated mazindol binding to subhypothalamic areas involvement in glucoprivic feeding. Brain Research Bulletin 17(6): 873-878, 1986

Central receptors and recognition sites mediating the effects of monoamines and anorectic drugs on feeding behavior. Clinical Neuropharmacology 13(5): 361-391, 1990

Development of anorectic NPY antagonists: possible roles of Y1 and Y5 receptors in feeding regulation. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 127(2): 88-91, 2006

Motivated feeding in the absence of glucoprivic control of feeding in rats. Journal of Comparative and Physiological Psychology 87(5): 801-807, 1974

Glucoprivic feeding and vasopressin. Society for Neuroscience Abstracts 11(1): 53, 1985

Metabolic and neurochemical correlates of glucoprivic feeding. Brain Research Bulletin 14(6): 617-624, 1985

Glucoprivic feeding and activity-based anorexia in the rat. Annals of the New York Academy of Sciences75(575): 490-492, 1989